Singapore legislation
Regulation 2
Regulation 2
Definitions
Subregulation 1
In these Rules, unless the context otherwise requires —[Deleted by S 555/2016 wef 01/11/2016][Deleted by S 555/2016 wef 01/11/2016](2) In these Rules —
any reference to an alkaloid shall include a reference to any salt of that alkaloid and in a case where the esters of an alkaloid are included in the Poisons List by virtue of the words, “its esters”, to any ester of that alkaloid; and
any reference to medicines for the internal treatment of human ailments shall include any medicine to be administered by hypodermic injection but shall not include a reference to gargles, mouth-washes, eye-drops, eye-lotions, ear-drops, preparations for naso-pharyngeal use, and douches for rectal, vaginal or urethral use.(3) Any reference in the Schedules to the percentage of a poison contained in any substance shall, unless otherwise expressly provided, be construed in the following manner, that is to say, a reference to a substance containing 1% of any poison means:
in the case of a solid, that one gramme of the poison is contained in every 100 grammes of the substance; and
in the case of a liquid, that one millilitre of the poison, or, if the poison itself is a solid, one gramme of the poison, is contained in every 100 millilitres of the substance,and so in proportion for any greater or lesser percentage.
Definition
“active ingredient” means any substance or compound that —
is usable in the manufacture of a health product under the Health Products Act 2007 as a pharmacologically active constituent; and
is specified as an active ingredient in the Schedule to the Health Products (Active Ingredients) Regulations 2023 (G.N. No. S 831/2023);
Definition
“animal” includes poultry;
Definition
“antimonial poisons” means chlorides of antimony, oxides of antimony, sulphides of antimony, antimonates, antimonites and organic compounds of antimony;
Definition
“arsenical poisons” means halides of arsenic, oxides of arsenic, sulphides of arsenic, arsenates, arsenites, copper aceto- arsenites, sodium thioarsenates and organic compounds of arsenic;
Definition
“British Pharmacopoeia” and “Pharmaceutical Codex” include the supplements and addenda thereto;
Definition
“cell, tissue and gene therapy product” means a health product under the Health Products Act 2007 which is categorised as a cell, tissue or gene therapy product in the First Schedule to that Act;
Definition
“Chinese proprietary medicine” has the same meaning as in the Medicines (Traditional Medicines, Homoeopathic Medicines and other Substances) (Exemption) Order (O 6);
Definition
“current edition”, in relation to any publication which describes a herbal substance in raw form, means an edition which is current at the time the herbal substance is sold or supplied, and includes any amendment, addition or deletion made to that edition of the publication up to that time;
Definition
“food” includes a beverage;
Definition
“licensed importer” means an importer licensed under the Act;
Definition
“licensed person” means a person licensed under the Act;
Definition
“licensed retail pharmacy” means premises specified in a pharmacy licence issued under the Health Products (Licensing of Retail Pharmacies) Regulations 2016 (G.N. No. S 330/2016);
Definition
“medical device” means a medical device referred to in the First Schedule to the Health Products Act 2007;
Definition
“mercurial poisons” means oxides of mercury, mercuric salts and organic compounds of mercury;
Definition
“registered nurse” means a nurse whose name is included in any part of the register of nurses maintained under the Nurses and Midwives Act 1999;
Definition
“sale by wholesale” means sale in any of the circumstances set out in section 8 of the Act;
Definition
“sell by retail”, in relation to any poison, means to sell the poison otherwise than by wholesale;
Definition
“therapeutic product” means a health product under the Health Products Act 2007 which is categorised as a therapeutic product in the First Schedule to that Act.